| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.105.000505 |
| P698 | PubMed publication ID | 16820557 |
| P50 | author | Johan Vijgen | Q90710843 |
| P2093 | author name string | Karen Hensen | |
| Paul Dendale | |||
| Jean-Luc Rummens | |||
| Marc Hendrikx | |||
| Paul Steels | |||
| Urbain Mees | |||
| Robert Geukens | |||
| Remco Koninckx | |||
| Eric Bijnens | |||
| Axel Jacobs | |||
| Dagmara Dilling | |||
| Christel Clijsters | |||
| Hanne Jongen | |||
| Michel Ingels | |||
| P433 | issue | 1 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| P304 | page(s) | I101-7 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial | |
| P478 | volume | 114 |
| Q43026554 | A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition |
| Q33755344 | A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. |
| Q34043802 | Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis |
| Q28082162 | Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials |
| Q38021450 | Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis |
| Q38499161 | Arrhythmia in stem cell transplantation |
| Q64271407 | Autologous bone marrow stem cell therapy for patients undergoing coronary artery bypass grafting: A meta-analysis of 14 randomized controlled trials |
| Q37837891 | Autologous cell therapy for cardiac repair. |
| Q38435541 | Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal S |
| Q37792119 | Blood Supply of the Graft After Cellular Cardiomyoplasty |
| Q34804229 | Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis |
| Q37783801 | Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy |
| Q33288008 | Bone marrow cell-mediated cardiovascular repair: potential of combined therapies |
| Q84940240 | Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure |
| Q85475678 | CD133-Positive Cells for Cardiac Stem Cell Therapy: Current Status and Outlook |
| Q38764929 | Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo. |
| Q40053814 | Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure |
| Q35144550 | Cardiac cell therapy: where we've been, where we are, and where we should be headed |
| Q34617472 | Cardiac regeneration using pluripotent stem cells--progression to large animal models. |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q33406980 | Cardiac repair with adult bone marrow-derived cells: the clinical evidence |
| Q38014708 | Cell delivery routes for stem cell therapy to the heart: current and future approaches. |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q37776514 | Cell therapy for heart failure: the need for a new therapeutic strategy |
| Q36964549 | Cell therapy in myocardial infarction: emphasis on the role of MRI. |
| Q88618933 | Cell therapy trials for heart regeneration - lessons learned and future directions |
| Q33713519 | Cell-based therapy for heart disease: a clinically oriented perspective |
| Q38859871 | Cellular Therapy for Heart Failure. |
| Q37124558 | Cellular replacement therapy for arrhythmia treatment: early clinical experience |
| Q34786321 | Clinical trials of cardiac repair with adult bone marrow- derived cells |
| Q52690932 | Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future. |
| Q37056280 | Concise Review: The Role of Clinical Trials in Deciphering Mechanisms of Action of Cardiac Cell-Based Therapy |
| Q37074696 | Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability |
| Q39231446 | Culture bag systems for clinical applications of adult human neural crest-derived stem cells. |
| Q37851149 | Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis. |
| Q36694346 | Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure |
| Q35509900 | Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients |
| Q35290282 | Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis |
| Q39654125 | Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34 + human cord blood fraction for effective therapeutic vascularization |
| Q36690614 | Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q56985687 | Global position paper on cardiovascular regenerative medicine |
| Q90451318 | How to Stimulate Myocardial Regeneration in Adult Mammalian Heart: Existing Views and New Approaches |
| Q44732593 | In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement |
| Q36861491 | Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair |
| Q37598908 | Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease |
| Q90655522 | Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia |
| Q42226249 | Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling |
| Q37609687 | Large animal models of heart failure: a critical link in the translation of basic science to clinical practice |
| Q37363514 | Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction |
| Q82038674 | Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study |
| Q35003611 | Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy |
| Q39626848 | Monocyte‐derived and CD34+/KDR+ endothelial progenitor cells in heart failure |
| Q41891677 | Moving beyond surrogate endpoints in cell therapy trials for heart disease |
| Q38050930 | Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review |
| Q35639798 | Protein localization in the plant Golgi apparatus and the trans-Golgi network |
| Q52724490 | Quality-Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ Cells. |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q33361149 | Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone |
| Q35626702 | Recent advances in the diagnosis and treatment of acute myocardial infarction |
| Q40625539 | Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality |
| Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
| Q33490304 | Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease |
| Q35001392 | Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system |
| Q37900396 | Stem Cell Therapy for Cardiac Disease: What Can Be Learned from Oncology |
| Q38114860 | Stem Cell Therapy for Heart Disease |
| Q34441749 | Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment |
| Q26866170 | Stem cell therapy for chronic heart failure: an updated appraisal |
| Q24194988 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure |
| Q30239945 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. |
| Q84282694 | Stem cell therapy for heart failure |
| Q24240357 | Stem cell therapy for ischaemic heart disease and congestive heart failure |
| Q34786978 | Stem cell therapy: MRI guidance and monitoring |
| Q36699597 | Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease |
| Q38063950 | Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome? |
| Q98165126 | Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial |
| Q37959064 | The proarrhythmic risk of cell therapy for cardiovascular diseases |
| Q36976439 | Therapeutic myocardial angiogenesis |
| Q33950809 | Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial |
| Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types |
| Q38256645 | Transplantation of bone marrow stem cells during cardiac surgery |
| Q37976268 | Update on cardiac stem cell therapy in heart failure |
| Q84563741 | [Surgical intramyocardial stem cell therapy for chronic ischemic heart failure] |
Search more.